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In November 1997, the Centers for Disease Control and Prevention (CDC) released revised
guidelines for lead poisoning screening, including a recommendation that states and regions
individualize screening policies based on local prevalence ofelevated lead levels. The purpose of
this study was to collect prevalence data for a Philadelphia, Pennsyvania, inner-city pediatric
outpatientpopulation previously not known to haveelevated bloodleadlevels in orderto deter-
mine its risk for lead expoure and screening requirements. Charts were reviewed for 817 chil-
dren of10 months through 6years ofagewhose venous bloodlead leveswereobtained aspart
oftheir routine health care over a 12-nmonth period ending October 1992. Noine ofthese chil-
dren had ahistoryofpreviousl el lead levels. Prevalence ofelevat l vels was deter-
mined for this population and correlt.ed with patient age, sex, r, a insuran tpe. More
than two-thirds (68%) ofthe studypatients had ablood leadlevel of.10 pgdl levat blood
lead levels were associated with blackr (p<0.0001), but not with x or insurance type. The
percentage ofchildren with elevated blood lead levels was highest at ages 3748 months. A
majorityofthechildren screenedhadleadlevels inexcess ofthe CDCthresholdforanabnormal
leadlevel (10 pg'dl). This is thehighest reported prevalence within a U.S. pediatric dinicpopu-
lation. In view ofthis exremely high prevalence, clinicians and public health personnel caring
forchildren in Philadelphia inner-cityclinics must followthe intentofthe newCDCguidelines
byincreasing theireff;orts in the areas ofscreening, follow-up, andenvironmental interventions.
To ensure alead-safe upbringing forchildren in the United States, statehealth officials nation-
wide should perform local risk ments before consideringpolicy transitions from universal
to targeted screening. Key words: lead poisoning, pediatric, prevalence, screening, urban.
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Despite significant national efforts, lead
poisoning continues to be a serious problem
for American children. In 1991 the Centers
for Disease Control and Prevention (CDC)
issued guidelines stating that virtually all
children were at risk for lead poisoning.
The CDC then recommended universal
screening of blood lead levels for all chil-
dren (1). The National Health and
Nutrition Examination Surveys (NHANES
III) reported in 1994 that an estimated 1.7
million American children had blood lead
levels exceeding 10 pg/dl. Black race, male
sex, and urban environment were cited by
the NHANES III report as substantial risk
factors for lead poisoning (2).
Studies have documented highly vari-
able and geographically diverse prevalences
ofblood lead levels .10 pg/dl, ranging from
5.6% in suburban clinics (3) to 71% in an
inner-city emergency department (4). Large
variations in lead poisoning prevalences
were reported within the confines of a sin-
gle city (5). Additionally, it was reported
that children in rural areas can also be at
significant risk for lead poisoning (6,7).
Given these widespread regional differ-
ences in elevated blood lead prevalence
data, in late 1997 the CDC released new
guidelines regarding lead screening (8).
These guidelines continue to reflect the
many adverse effects ofchildhood lead poi-
soning, which have been documented at
levels as low as 10 pg/dl (9-23). The new
guidelines replaced the blanket recommen-
dation for universal screening with a pref-
erence for regional screening policies.
These policies are based on several factors
including local prevalences of elevated
blood lead levels and the percentage of
houses built before 1950 (8), which are
more likely to have lead-containing paint
(24,25). The purpose of the present study
was to determine the prevalence ofelevated
blood lead levels in an inner-city
Philadelphia, Pennsylvania, pediatric pop-
ulation in order to help develop local
screening policies.
Methods
We reviewed the charts ofall 2,334 patients
of 10 months through 6 years ofage under-
going blood lead level testing at the inner-
city Hahnemann University General
Pediatric Clinic in the 12-month period
ending 7 October 1992. Of these, 1,517
patients were exduded from the study due
to a history of lead poisoning. Therefore,
the study population consisted of the
remaining 817 patients who underwent
blood lead screening as part oftheir routine
health care in this pediatric clinic.
Venous blood samples were obtained
from each child as per the 1991 CDC rec-
ommendations for lead specimen sample
collection (1). Samples were analyzed by the
Philadelphia Department of Public Health
using the atomic absorption spectrophotom-
etry method. The Philadelphia Department
of Public Health lead testing laboratory is
registered with the Pennsylvania State
Quality Assurance Program, which requires
daily quality control measures. Statistical
comparisons were performed using chi-
square analysis.
Results
The 817 subjects (45.7% male) averaged
24.8 months ofage; 702 (85.8%) were black,
59 (7.2%) were Hispanic, and 34 (4.1%)
were white. Medical insurance distribution
was as follows: 628 (76.9%) received medical
assistance or the equivalent; 151 (18.4%)
were privately insured; and 38 (4.7%) had no
insurance. The patient blood lead levels were
distributed as follows: 265 (32%) had levels
below 10 pg/dl; 275 (34%) had levels of
10-14 pg/dl, 137 (17%) had levels of 15-19
pg/dl, and 140 (17%) hadlevels >20 pg/dl.
In this studypopulation, the prevalence of
elevated blood lead levels peaked in children
37-48 months of age (Fig. 1). Seasonality
findings were similar to those of previous
studies (26,27), with the prevalence ofelevat-
ed blood lead levels lowest in winter months
(December andJanuary) and highest in May.
Black children were much more likely to
demonstrate elevated blood lead levels in
comparison to other subjects in this study
(p<O.0001). There was no significant correla-
tion between the patient's sex and type of
insurance coverage and the risk of elevated
bloodleadlevels.
Discussion
The results ofthisstudy indicate that 68% of
the Philadelphia inner-city pediatric clinic
population tested at our site had blood lead
levels .10 pg/dl. This is the highest reported
prevalence in a U.S. general pediatric clinic
population. This finding is consistent with
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previous documented associations between
high prevalance ofelevated blood lead levels
and urban environments (8,28). Other
studies conducted in pediatric clinic settings
have reported much lower prevalence data,
ranging from 6.1% (29) to 30% (30). In
contrast, the handful of previous studies
that reported similarly high prevalences of
elevated blood lead levels investigated spe-
cialized patient populations (4,31,32). For
example, Flaherty (31) screened a popula-
tion of abused and neglected children in
Chicago, Illinois, and found that 64.7%
had blood lead levels >10 pg/dl. A report
from Oakland, California, showed a 67%
prevalence ofelevated blood lead levels, but
the screening site was selected on the basis
of its older housing (32). Finally, Wiley et
al. (4) demonstrated 50-71% prevalences
of elevated blood lead levels in children
screened during emergency room visits (4).
We believe that our findings from the
1991-1992 screening are representative ofa
continuing lead hazard in the Philadelphia
area because a recent report by the
Philadelphia Department of Public Health
found only a small decrease (from 44.3% to
39.9%) in the overall prevalence ofelevated
blood lead levels between 1993 and 1996
(33). The higher prevalence ofelevatedblood
lead levels in our study in comparison to the
Philadelphia Department ofPublic Health
report mayreflect thehigherconcentration of
inner-citypatients inourclinic's population.
The prevalence results reported in this
study are not those of the full pediatric
clinic population. Children with previously
known elevated blood lead levels were
exduded from the study in order to avoid
oversampling those children recalled to the
clinic for management of elevated blood
lead levels. Projection of our data to the
full pediatric clinic population would
therefore underestimate the actual preva-
lence ofelevated blood lead levels.
When the 1991 CDC guidelines called
for universal screening, studies documented
significant numbers ofphysicians (8-10%)
who were noncompliant with this recom-
mendation (34,35). Some public health per-
sonnel therefore may use the new CDC
guidelines tojustifyran overall decrease in the
effort and resources expended on blood lead
screening. However, the new CDC guide-
lines dearly mandate that state and regional
public health agencies must determine that a
population in an individual region is at low-
risk for lead poisoning before initiation of
selective screeningprocedures.
The newCDC guidelines also emphasize
the need to focus screening efforts on chil-
dren 1-2 years ofage. Our study findings
indicate that a majority ofour 3-6-year-old
patients had blood lead levels .10 pg;/dI even
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Figure 1. Distribution of elevated blood lead levels by age.
though they were not previously known to
have had lead poisoning. Therefore, normal
blood lead levels at ages 1 and 2 years may
not reliably predict negative results at ages
3-6years. Furtherstudies maybe required to
establish appropriate ages during which to
screen patients in areas with a high preva-
lence ofelevated bloodleadlevels.
Our findings of an unexpectedly high
prevalence ofelevated blood lead levels in a
Philadelphia inner-city clinic population
support the new CDC recommendations
regarding the need for careful documenta-
tion ofblood lead prevalence data in indi-
vidual regions. Clinicians and public health
personnel caringfor children in Philadelphia
inner-city clinics must follow the intent of
the new CDC guidelines by increasing their
efforts in screening, follow-up, and environ-
mental intervention. Finally, in order to
ensure a lead-safe upbringing for children in
the United States, state health officials
nationwide should perform local risk assess-
ments before considering policy transitions
from universal to targetedscreening.
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Excellence in basic research at the
National Institute of Environmental Health Sciences
NIEHS scientists and grantees are performing basic studies of our susceptibility to environment-related disease:
demonstrating that a carcinogen in cigarette smoke (benzo(o)pyrene) alters part of a gene to cause lung cancer ...
showing the effects offetal exposure to PCBs . . . developing a strain of mouse that lacks functional estrogen receptors
and that helps evaluate how some pesticides and other estrogen-like compounds might affect devdelopment and
reproduction ... discovering the genes for breast, ovarian, and prostate cancers... ident
days offeirtility ... seeking to reverse the damage from lead exposure .. . finding alte-
t.. . . pinpointing the functions ofspecific genes by eliminating them from specially bred
Rg orinar yeast cells, to isolate and clone genes and other fragments of genetic
Eeffects ofurban air on lung function ...
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